MedPath

Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy

Phase 3
Completed
Conditions
Hemangiomas
Registration Number
NCT00312520
Lead Sponsor
The Hospital for Sick Children
Brief Summary

The purpose of the study is to determine if pulse steroids are more efficacious and safer than the standard treatment with oral corticosteroids.

Detailed Description

Currently there is no prospective study in hemangioma patients answering critical questions such as: which type of steroid should be used,how much should we use and for how long. This study is an investigator blinded study with two arms:one arm is receiving standard treatment with daily oral corticosteroids and the other is receiving intravenous pulse corticosteroids daily for 3 days, monthly for 3 months. The main outcome of the study is assess the efficacy of each treament modality as the percentage improvement in the hemangioma's appearance. The secondary outcomes are the safety profiles of the two drugs and the changes in the angiogenesis markers as a result of treatment intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • problematic facial hemangiomas (periorbital/facial hemangiomas with potential visual obstruction, large/dysfiguring hemangiomas)
  • 1-4 months of age
  • signed consent form
Exclusion Criteria
  • refusal to participate
  • age > 4 months
  • complicated nonvisible hemangiomas
  • congenital heart disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percent improvement in the appearance of hemangioma
Secondary Outcome Measures
NameTimeMethod
Frequency of side-effects experienced by the patients
Changes in the angiogenesis markers

Trial Locations

Locations (1)

The Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath